Lexicon Pharmaceuticals, Inc. (LXRX)
NASDAQ: LXRX · Real-Time Price · USD
1.715
-0.005 (-0.29%)
Apr 13, 2026, 1:31 PM EDT - Market open
Lexicon Pharmaceuticals Market Cap
Lexicon Pharmaceuticals has a market cap or net worth of $726.61 million as of April 13, 2026. Its market cap has increased by 511.11% in one year.
Market Cap
726.61M
Enterprise Value
690.50M
1-Year Change
511.11%
Ranking
Category
Stock Price
$1.72
Market Cap Chart
Since April 7, 2000, Lexicon Pharmaceuticals's market cap has decreased from $890.90M to $726.61M, a decrease of -18.44%. That is a compound annual growth rate of -0.78%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 10, 2026 | 728.70M | 74.37% |
| Dec 31, 2025 | 417.90M | 56.46% |
| Dec 31, 2024 | 267.10M | -28.72% |
| Dec 29, 2023 | 374.70M | 3.94% |
| Dec 30, 2022 | 360.50M | -38.54% |
| Dec 31, 2021 | 586.60M | 45.99% |
| Dec 31, 2020 | 401.80M | -8.89% |
| Dec 31, 2019 | 441.00M | -37.30% |
| Dec 31, 2018 | 703.30M | -32.58% |
| Dec 29, 2017 | 1.04B | -27.50% |
| Dec 30, 2016 | 1.44B | 4.32% |
| Dec 31, 2015 | 1.38B | 194.45% |
| Dec 31, 2014 | 468.40M | -49.30% |
| Dec 31, 2013 | 923.80M | -18.41% |
| Dec 31, 2012 | 1.13B | 159.94% |
| Dec 30, 2011 | 435.60M | -10.39% |
| Dec 31, 2010 | 486.10M | 62.74% |
| Dec 31, 2009 | 298.70M | 55.98% |
| Dec 31, 2008 | 191.50M | -53.80% |
| Dec 31, 2007 | 414.50M | 50.51% |
| Dec 29, 2006 | 275.40M | 16.89% |
| Dec 30, 2005 | 235.60M | -52.10% |
| Dec 31, 2004 | 491.90M | 33.02% |
| Dec 31, 2003 | 369.80M | 49.35% |
| Dec 31, 2002 | 247.60M | -58.67% |
View and export this data all the way back to 2000. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Maravai LifeSciences Holdings | 789.20M |
| Solid Biosciences | 789.10M |
| Kura Oncology | 765.82M |
| Relmada Therapeutics | 763.06M |
| Design Therapeutics | 749.32M |
| MeiraGTx Holdings | 730.57M |
| Alto Neuroscience | 727.72M |
| Tenax Therapeutics | 725.58M |